Andreas Rosenwald

3.5k total citations
69 papers, 1.9k citations indexed

About

Andreas Rosenwald is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Andreas Rosenwald has authored 69 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pathology and Forensic Medicine, 23 papers in Oncology and 22 papers in Immunology. Recurrent topics in Andreas Rosenwald's work include Lymphoma Diagnosis and Treatment (23 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Viral-associated cancers and disorders (9 papers). Andreas Rosenwald is often cited by papers focused on Lymphoma Diagnosis and Treatment (23 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Viral-associated cancers and disorders (9 papers). Andreas Rosenwald collaborates with scholars based in Germany, United States and Spain. Andreas Rosenwald's co-authors include Louis M. Staudt, Gunnar W. Klau, Thomas Dandekar, Marcus Dittrich, Tobias Müller, Elı́as Campo, W. Michael Kuehl, Arthur L. Shaffer, Elaine M. Hurt and P. Leif Bergsagel and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Andreas Rosenwald

63 papers receiving 1.8k citations

Peers

Countries citing papers authored by Andreas Rosenwald

Since Specialization

Citations

This map shows the geographic impact of Andreas Rosenwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Rosenwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Rosenwald more than expected).

Fields of papers citing papers by Andreas Rosenwald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Rosenwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Rosenwald. The network helps show where Andreas Rosenwald may publish in the future.

Co-authorship network of co-authors of Andreas Rosenwald

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Rosenwald. A scholar is included among the top collaborators of Andreas Rosenwald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Rosenwald. Andreas Rosenwald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Maintenance of CD19 Expression after Tafasitamab Treatment in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) from Clinical Trial and Real-World Settings 2025 ·Transplantation and Cellular Therapy ·Johannes Duell, Diana Alvarez Arias, Hilka Rauert‐Wunderlich, Florian Eisele, Alla Volgina, (unknown), Thomas Stauffer Larsen, Andreas Rosenwald	1
2	Fibrin-associated large B-cell lymphoma arising in a cystic lymphangiomatous lesion of the adrenal gland: A case report and overview of the entity 2025 ·Pathology - Research and Practice ·Stefan Kircher, (unknown), Katja Maurus, (unknown), Max S. Topp, Anna Katharina Seitz, (unknown), Karen Ernestus, Ioannis Anagnostopoulos, Andreas Rosenwald, Elena Hartmann	1
3	Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphoma 2025 ·Molecular Therapy ·Zeno Riester, (unknown), Nicole Seifert, (unknown), Arindam Ghosh, (unknown), Justus Weber, Reto Gianotti, (unknown), Miriam Alb, Thomas Nerreter, Elena Hartmann, Andreas Rosenwald, Markus Sauer, Ekkehard Moessner, Hermann Einsele, Claudia Ferrara, Christian Klein, (unknown), Sophia Danhof	0
4	Rapid response to selpercatinib in RET fusion positive pancreatic neuroendocrine carcinoma confirmed by smartwatch 2024 ·npj Precision Oncology ·Barbara Deschler-Baier, (unknown), Matthias Kroiß, Manik Chatterjee, Daniel Gündel, (unknown), Alexander Kerscher, Volker Kunzmann, Silke Appenzeller, Katja Maurus, Andreas Rosenwald, Ralf C. Bargou, Elena Hartmann, Vivek Venkataramani	0
5	Maintenance of CD19 Expression after Tafasitamab Treatment in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) from Clinical Trial and Real-World Settings 2024 ·Blood ·Johannes Duell, Diana Alvarez Arias, Hilka Rauert‐Wunderlich, Florian Eisele, Alla Volgina, (unknown), Thomas Stauffer Larsen, Andreas Rosenwald	0
6	What is new in the 5th edition of the World Health Organization classification of mature B and T/NK cell tumors and stromal neoplasms? 2024 ·Journal of Hematopathology ·Ayoma D. Attygalle, John K. Chan, Sarah E. Coupland, Ming‐Qing Du, Judith A. Ferry, Daphne de Jong, Dita Gratzinger, Megan S. Lim, Alina Nicolae, German Ott, Andreas Rosenwald, Anna Schuh, Reiner Siebert, (unknown)	1
7	Delayed and limited administration of the JAKinib tofacitinib mitigates chronic DSS-induced colitis 2023 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Andreas Rosenwald, Johannes Wiest, Friederike Berberich‐Siebelt	4
8	Recent Advances in Castleman Disease 2022 ·Oncology Research and Treatment ·Christian Hoffmann, Marcus Hentrich, Markus Tiemann, Andreas Rosenwald, Florian Weber, Wolfgang Willenbacher, Kai Hübel	15
9	EMT, Stemness, and Drug Resistance in Biological Context: A 3D Tumor Tissue/In Silico Platform for Analysis of Combinatorial Treatment in NSCLC with Aggressive KRAS-Biomarker Signatures 2022 ·Cancers ·(unknown), Claudia Göttlich, (unknown), (unknown), (unknown), F. Schmitt, (unknown), (unknown), (unknown), (unknown), Danjouma Cheufou, (unknown), Andreas Rosenwald, (unknown), Thorsten Walles, Julia Schüler, Thomas Dandekar, Sarah Nietzer, Gudrun Dandekar	10
10	A large retroperitoneal lipoblastoma as an incidental finding: a case report 2021 ·BMC Pediatrics ·Elena Hartmann, Verena Wiegering, (unknown), Thomas Meyer, Andreas Rosenwald, Katja Maurus, Karen Ernestus	5
11	R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement 2021 ·Journal of Cancer Research and Clinical Oncology ·(unknown), (unknown), Andreas Rosenwald, Elena Hartmann, Anke Heidemeier, Hermann Einsele, Max S. Topp, Johannes Duell	5
12	Identification of Candida albicans regulatory genes governing mucosal infection 2018 ·Cellular Microbiology ·(unknown), Elena Hartmann, (unknown), Eva Guiducci, Florian Kirchner, Andreas Rosenwald, Salomé LeibundGut‐Landmann, J. Christian Pérez	23
13	Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL 2016 ·Annals of Oncology ·Karoline Koch, Eva Hoster, Marita Ziepert, Michael Unterhalt, German Ott, Andreas Rosenwald, Martin L. Hansmann, (unknown), Harald Stein, Viola Pöschel, Martin Dreyling, Lorenz Trümper, Markus Löffler, Norbert Schmitz, Wolfgang Hiddemann, Michael Pfreundschuh, W. Klapper	42
14	Allogeneic or autologous transplantation as first-line therapy for younger patients with peripheral T-cell lymphoma: Results of the interim analysis of the AATT trial. 2015 ·Journal of Clinical Oncology ·Norbert Schmitz, Maike Nickelsen, Bettina Altmann, Marita Ziepert, Kamal Bouabdallah, Christian Gisselbrecht, (unknown), Guillaume Cartron, Emmanuel Gyan, Arnaud Jaccard, Laurence Sanhès, Philippe Gaulard, Andreas Rosenwald, Lorenz Truemper, Bertram Glaß, Peter Reimer, Wolfgang Herr, Martin Wilhelm, Olivier Tournilhac	18
15	Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas 2015 ·Clinical Oral Investigations ·Tim Schneider, (unknown), Christian Linz, Roman C. Brands, Stefan Hartmann, (unknown), Andreas Rosenwald, Alexander Kübler, Urs Müller‐Richter	8
16	Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse 2013 ·Haematologica ·Martin Wartenberg, (unknown), (unknown), German Ott, Andreas Rosenwald, Falko Fend, Marcus Kremer	27
17	Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis 2012 ·PLoS ONE ·(unknown), (unknown), Elena Hartmann, Ellen Leich, Andreas Rosenwald, Edgar Serfling, Mathias Buttmann, Friederike Berberich‐Siebelt	38
18	Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance 2011 ·Haematologica ·Preetesh Jain, (unknown), (unknown), Percy Chiu, (unknown), Rajendra N. Damle, (unknown), Filiz Şen, Lynne V. Abruzzo, Jan A. Burger, Andreas Rosenwald, Steven L. Allen, Jonathan E. Kolitz, Michael R. Kanost, Nicholas Chiorazzi, Barbara Sherry	63
19	Leiomyolipoma of the Orbit 2011 ·Ophthalmic Plastic and Reconstructive Surgery ·Maria Borrelli, (unknown), (unknown), Andreas Rosenwald, L. Solymosi, Thomas Günthner‐Lengsfeld, Gerd Geerling	3
20	Deletions in the long arm of chromosome 10 in lymphomas with t(14;18): a pathogenetic role of the tumor supressor genes PTEN/MMAC1 and MXI1? 1998 ·Blood ·Reiner Siebert, Stefan Gesk, Svetlana Harder, (unknown), Peter Matthiesen, W. Grote, Brigitte Schlegelberger, Burkhard Jandrig, (unknown), Siegfried Scherneck, Andreas Rosenwald, German Ott	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact